Use Intermountain Connect Care® Get care for low-level urgent conditions through a video chat with a provider, 24/7, on your computer or mobile device.Learn More.
Get in Line at InstaCare® View wait times and save your place in line at an Intermountain InstaCare location near you.
January 18, 2024 Intermountain Precision Genomics Discontinuing Laboratory Services Media Contact Intermountain Health will close and divest its Precision Genomics Laboratory service on February 1, 2024. Full Story
August 8, 2023 Myriad Genetics e Intermountain Health participan en ComboMATCH, un ensayo clínico nacional para el progreso del tratamiento del cáncer Media Contact En el estudio ComboMATCH, se utilizan pruebas genéticas para asignar tratamientos específicos a pacientes que tienen cáncer avanzado. Full Story
August 8, 2023 Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment Media Contact Myriad Genetics, Inc., a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, part of the Intermountain Health system, will begin providing oncology test results that allow access to the ComboMATCH trials. Full Story
April 18, 2023 Intermountain Precision Genomics and Myriad Genetics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification Media Contact Intermountain Precision Genomics Laboratory receives certification from NYS Department of Health Clinical Laboratory Evaluation Program. Intermountain Precision Genomics, a service of Intermountain Health, and partner Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, are now certified to offer solid tumor testing to patients in all 50 U.S. states after receiving the New York State Clinical Laboratory Permit. This achievement follows a recent site inspection as part of the New York State Department of Health Clinical Laboratory Evaluation Program. Full Story
February 15, 2023 Intermountain Precision Genomics Eliminating 38 Positions Media Contact 38 positions within Precision Genomics at Intermountain Health will be ended on March 20, 2023. These positions are from multiple areas within Precision Genomics located in Utah. Full Story
August 22, 2022 Innovador estudio de genómica infantil en Intermountain Primary Children’s El hospital alcanza un hito en cuanto a inscripciones Media Contact Innovador HerediGene: Children's Study alcanza el hito de 2500 inscritos. Full Story
August 22, 2022 Groundbreaking Children’s Genomics Study at Intermountain Primary Children’s Hospital Reaches Enrollment Milestone Media Contact Largest DNA mapping effort ever undertaken in kids reaches 2,500 enrollees Full Story
June 10, 2022 Downwinders Compensation Program Law Extended Two Years – Informational Meetings Offered for Individuals Affected by Exposure Media Contact Information Meetings in southern Utah June 28, 29, and 30 Full Story
April 7, 2022 Genetic Research Study Surpasses 100K Participants Revealing Discoveries to Help Patients with Serious Diseases Media Contact More than 100,000 people have enrolled in Intermountain Healthcare’s HerediGene: Population Study, and these participants are contributing to discoveries benefitting the world in health care and science. Full Story
September 27, 2021 Groundbreaking Children’s Genomics Study at Intermountain Primary Children’s Hospital Provides New Options for Children to Participate Media Contact The groundbreaking HerediGene: Children’s Study – the world’s largest DNA mapping effort ever to be undertaken in kids – is now offering additional collection methods for children to participate at Intermountain Primary Children’s Hospital, including a new simple cheek swab. Full Story
